Dexcom (DXCM) Total Current Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Total Current Liabilities data on file, last reported at $2.2 billion in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $2.2 billion, down 26.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 billion (down 26.78% YoY), and the FY2025 annual result was $2.1 billion, down 26.93% from the prior year.
• Total Current Liabilities rose to $2.2 billion in Q1 2026 per DXCM's latest filing, from $2.1 billion in the prior quarter.
• Over five years, Total Current Liabilities peaked at $3.3 billion in Q3 2025 and troughed at $711.4 million in Q1 2022.
• A 5-year average of $2.0 billion and a median of $1.8 billion in 2022 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2023 and 2025: Total Current Liabilities soared 162.16% in 2023, then fell 26.93% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $1.8 billion in 2022, then declined by 15.4% to $1.6 billion in 2023, then jumped by 88.43% to $2.9 billion in 2024, then slipped by 26.93% to $2.1 billion in 2025, then increased by 3.79% to $2.2 billion in 2026.
• Business Quant data shows DXCM's Total Current Liabilities at $2.2 billion in Q1 2026, $2.1 billion in Q4 2025, and $3.3 billion in Q3 2025.